The prevailing view is that signaling machineries for the neurotransmitter GABA are also expressed by cells outside the CNS. In cultured murine calvarial osteoblasts, mRNA was constitutively expressed for both subunits 1 and 2 of metabotropic GABA B receptor (GABA B R), along with inhibition by the GABA B R agonist baclofen of cAMP formation, alkaline phosphatase (ALP) activity, and Ca 2؉ accumulation. Moreover, baclofen significantly inhibited the transactivation of receptor activator of nuclear factor-B ligand (RANKL) gene in a manner sensitive to a GABA B R antagonist, in addition to decreasing mRNA expression of bone morphogenetic protein-2 (BMP2), osteocalcin, and osterix. In osteoblastic MC3T3-E1 cells stably transfected with GABA B R1 subunit, significant reductions were seen in ALP activity and Ca 2؉ accumulation, as well as mRNA expression of osteocalcin, osteopontin, and osterix. In cultured calvarial osteoblasts from GABA B R1-null mice exhibiting low bone mineral density in tibia and femur, by contrast, both ALP activity and Ca 2؉ accumulation were significantly increased together with promoted expression of both mRNA and proteins for BMP2 and osterix. No significant change was seen in the number of multinucleated cells stained for tartrate-resistant acid phosphatase during the culture of osteoclasts prepared from GABA B R1-null mice, whereas a significant increase was seen in the number of tartrate-resistant acid phosphatase-positive multinucleated cells in co-culture of osteoclasts with osteoblasts isolated from GABA B R1-null mice. These results suggest that GABA B R is predominantly expressed by osteoblasts to negatively regulate osteoblastogenesis through down-regulation of BMP2 expression toward disturbance of osteoclastogenesis after down-regulation of RANKL expression in mouse bone.In the mammalian CNS, GABA is the major inhibitory amino acid neurotransmitter with two major receptor subtypes categorized into ionotropic and metabotropic receptors on the basis of homologous intracellular signals (1). The ionotropic GABA A receptor is a heteromeric protein complex composed of a number of different receptor subunits, whereas the GABA C R is derived from an assembly between various isoforms of the subunit (2). The metabotropic GABA B R belongs to a superfamily of the seven-transmembrane-domain receptors with high similarity to metabotropic receptors for the central excitatory amino acid neurotransmitter L-glutamic acid (3). The GABA B R couples to adenylyl cyclase through trimeric G-proteins to negatively regulate intracellular cAMP formation, in addition to inhibiting voltage-sensitive Ca 2ϩ channels and activating voltage-sensitive K ϩ channels, respectively. The GABA B R is orchestrated by a heterodimer comprised of members of GABA B R1 and GABA B R2 subunits, neither of which is fully functional when individually expressed. Any GABA B R1 subunits are unable to activate K ϩ channels alone (4), whereas heterodimerization between GABA B R1 and GABA B R2 subunits is required for the orchestration ...